6,7-dimethoxy-N-(4-nitrophenyl)quinazoli
CAS No. 765899-28-3
6,7-dimethoxy-N-(4-nitrophenyl)quinazoli( —— )
Catalog No. M19360 CAS No. 765899-28-3
6,7-dimethoxy-N-(4-nitrophenyl)quinazoli
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 45 | In Stock |
|
| 25MG | 65 | In Stock |
|
| 50MG | 105 | In Stock |
|
| 100MG | 162 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name6,7-dimethoxy-N-(4-nitrophenyl)quinazoli
-
NoteResearch use only, not for human use.
-
Brief Description6,7-dimethoxy-N-(4-nitrophenyl)quinazoli
-
Description6,7-dimethoxy-N-(4-nitrophenyl)quinazoli
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number765899-28-3
-
Formula Weight326.31
-
Molecular FormulaC16H14N4O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[O-][N+](=O)c1ccc(cc1)Nc3ncnc2cc(OC)c(cc23)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Galocitabine
Galocitabine (Neofrutulon), a thymidylate synthase inhibitor, is used potentially for the treatment of cancer.
-
MDH1-IN-2
MDH1-IN-2 (7c) is a potent MDH1 inhibitor with an IC50 of 2.27 μM for MDH1 and 27.47 μM for MDH2. MDH1-IN-2 has potential anticancer activity and can be used in the study of diseases related to the immune system.
-
KHK-IN-1
KHK-IN-1 is a reversible and ATP-competitive inhibitor of ketohexokinase (KHK) with IC50 of 12 nM. In the ATP-binding region of KHK, KHK-IN-1 interacts with Asp-27B.
Cart
sales@molnova.com